Evaluation of SARS-CoV-2-specific Serum parameter in Blood of Patients with present post COVID (VANCOV-01)
Recruiting
- Conditions
- U09.9Post COVID-19 condition, unspecified
- Registration Number
- DRKS00032918
- Lead Sponsor
- VANUDIS GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Signed informed consent
-Ability to consent
-Confirmed infection with Corona virus SARS-CoV-2
-Confirmed infection not older than 18 months
-No severe chronic underlying disease at the time-point of SARS-CoV-2 infection
Exclusion Criteria
-Any disease or condition which does not allow blood-sampling (jugded by the study investigator)
-severe chronic disease which was present before SARS-CoV-2 infection
-prior Plasmapheresis or Immuno-adsorption procedures
-Current smoker or ex-smoker (<5 years)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of differences in laboratory- and immuno-parameters in post COVID patients compared to control.
- Secondary Outcome Measures
Name Time Method Comparison of signatures with the results of the COVIAS trials